Label: information for the user
ABIMOX 5 mg/ml eye drops in solution
moxifloxacino
Read the entire label carefully before starting to use the medication, as it contains important information for you.
Contents of the package and additional information
Abimox eye drops are used for the treatment of eye infections (conjunctivitis) caused by bacteria. The active ingredient is moxifloxacino, an ophthalmic antiinfective.
Antibiotics are used to treat bacterial infections and do not work for viral infections such as the flu or a cold.
It is essential that you follow the instructions regarding the dose, administration interval, and treatment duration indicated by your doctor.
Do not store or reuse this medication. If you have any leftover antibiotic after treatment, return it to the pharmacy for proper disposal. Do not dispose of the medication through the drain or in the trash.
Do not use Abimox
Warnings and precautions
Consult your doctor or pharmacist:
Like any antibiotic,theuse ofAbimoxfor a long timemay lead to other infections.
Use of other medications with Abimox
Inform your doctor or pharmacist if you are using or have recently used other medications, including those purchased without a prescription.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication.
Driving and operating machinery
You may experience blurred vision after using Abimox. Do not drive or operate machinery until these effects have resolved.
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Abimox should only be used to apply drops in the eyes.
The recommended dose is:
Adults, including elderly patients and children:1 dropin the affected eye or eyes,3 times a day(in the morning, in the afternoon, and at night).
This medication should only be applied in both eyes if your doctor has recommended it.
Abimox can be used in children, in patients over 65 years old, and in patients with kidney or liver problems. The information on the use of this medication in newborns is very limited, and therefore it is not recommended for use in these patients.
Normally, the infection improves in 5 days. If you do not observe improvement, consult your doctor. You should continue using the drops for 2-3 days more or for the entire period of time indicated by your doctor.
Howtousethismedication
If a drop falls outside the eye, try again.
If more medication than necessary has been applied
You can remove it by rinsing your eyes with warm water. Do not apply more drops until it is time for the next dose.
If Abimox is accidentallyswallowed
Contact your doctor or pharmacist.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to use Abimox
Continue with the next dose that was scheduled.Do notapply a double dose to compensate for the missed dose.
If you are using other eye drops
Wait at least 5 minutes between applying Abimox and the other drops.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, Abimox can cause side effects, although not everyone will experience them.
Unless the side effects are severe or you suffer a severe allergic reaction, continue with the treatment as normal.
If you experience a severe allergic reaction and any of the following symptoms appear:swelling of the hands, feet, ankles, face, lips, mouth, or throat that may cause difficulty swallowing or breathing, rash or urticaria, large blisters filled with fluid, wounds, and ulceration,stop using Abimox immediately and contact your doctor immediately.
Frequent:May affect up to 1 in 10 patients
Eye effects:eye pain, eye irritation
Occasional:May affectup to 1 in 100 patients
Eye effects:dry eye, eye itching, eye redness, inflammation or scarring of the eye surface, rupture of a blood vessel in the eye, abnormal sensation in the eye, abnormality, itching, redness, or swelling in the eyelid.
General side effects:headache and bad taste
Rare:May affect up to 1 in 1,000 people
Eye effects:corneal disorder, blurred or reduced vision, conjunctival inflammation or infection, eye fatigue, ocular swelling
General side effects:vomiting, nasal discomfort, sensation of a lump in the throat, decreased iron in the blood, abnormal liver function test values, abnormal skin sensation, pain, throat irritation
Frequency not known:cannot be estimatedfrom the available data
Eye effects:eye infection, eye surface clouding, corneal edema, deposits on the eye surface, increased eye pressure, scratch on the eye surface, ocular allergy, eye secretion, increased tear production, light sensitivity.
General side effects:shortness of breath, irregular heart rhythm, dizziness, increased allergic symptoms, itching, rash, skin redness, nausea, and urticaria.
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: https://www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the bottle and on the box after “CAD.” The expiration date corresponds to the last day of the month indicated.
This medication does not require special storage conditions.
To prevent infections, discard the bottle 4 weeks after the first opening.Write the opening date of the bottle in the space provided for this purpose in the case.
Medications should not be thrown down the drains or in the trash. Deposit the containers and medications you no longer need at the SIGRE collection pointat the pharmacy. Ask your pharmacist how to dispose of the containers and medications you no longer need. By doing so, you will help protect the environment.
Composition of Abimox
One mL of solution contains 5 mg of moxifloxacino (as moxifloxacino hydrochloride 5.45 mg).
One drop of eye drops contains 190 micrograms of moxifloxacino.
Appearance of the product and contents of the packaging
This medicine is a liquid (a transparent, yellowish-green solution) that is presented in a box containing a 5 mL plastic vial with a screw cap.
Holder of the marketing authorization and responsible forthemanufacturing
Holder of the marketing authorization
TIEDRA FARMACÉUTICA, S.L.
C/ Colón, 7
30510 Yecla (Murcia)
Spain
Responsible forthemanufacturing
PHARMATHEN S.A.
Dervenakion 6
15351 Pallini
Attikis
Greece
FAMAR S.A.
Plant A
Agiou Dimitriou Street 63
174 56 Alimos
Athens
Greece
This medicine is authorized in the member states of the European Economic Area with the following names:
Denmark:Moxifloxacin/Pharmathen 5mg/ml Eye drops, solution
Spain:Abimox 5 mg/ml eye drops in solution
Greece:Tamvelier 5mg/ml Eye drops, solution
Date of the last review of this leaflet:November2019
The detailed and updated information on this medicine is available on the website of the Spanish Agency of Medicaments and Health Products (AEMPS)http://www.aemps.gob.es
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.